Searchable abstracts of presentations at key conferences in endocrinology
Poster Presentations
Bone
Does preoperative localisation for total parthyroidectomy in patients with renal failure improve outcome?
Derriford Hospital, Plymouth, UK.
ea0025p1
Influence of age and gender on expression of primary hyperparathyroidism
Postgraduate Institute of Medical Education and Research, Chandigarh, India.
ea0025p2
Evaluation of the association between serotonin and bone mineral density in patients with neuroendocrine tumours
Barts and the London School of Medicine, QMUL, London, UK.
ea0025p3
Management of hypovitaminosis D in patients with primary hyperparathyroidism
Bradford Teaching Hospitals NHS Trust, Bradford, UK.
ea0025p4
Risk factors for femoral neck fracture in Indian postmenopausal women (BMD, Vitamin D study and Propensity for a fall)
Christian Medical College, Vellore, India.
ea0025p5
Effect of age and gender on bone turnover markers: relationships with oestradiol and parathyroid hormone
Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.
ea0025p6
Vitamin D insufficiency in hyperparathyroidism
1University of Hull, Hull, UK; 2Hull and East Yorksire Hospitals NHS Trust, Hull, UK.
ea0025p7
Thyrostimulin expression and signalling in the skeleton
Bassett J H Duncan
Hernandez Rebecca
Combs Charlotte
Spek Anne van der
Yu Ming
Williams Allan
Murphy Elaine
Boyde Alan
van Zeijl Clementine J J
Boelen Anita
Williams Graham R
1Molecular Endocrinology Group, Department of Medicine and Medical Research Council Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London W12 0NN, UK; 2Oral Growth and Development, Institute of Dentistry, Bart’s and London School of Medicine, Queen Mary, University of London, London E1 1BB, UK; 3Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
ea0025p8
Bone mineral density in patients with primary adrenal insufficiency compared to patients with congenital adrenal hyperplasia
1Charité Campus Mitte, Berlin, Germany; 2Endokrinologikum, Berlin, Germany.
ea0025p9
Serum 25-OH-vitamin D levels in thalassaemia major
The Whittington Hospital NHS Trust, London, UK.
ea0025p10
Bone turnover markers in patients on aminobisphosphonate therapy for osteoporosis
1Department of Endocrinology, St Vincent’s Hospital, Dublin, Ireland; 2Metabolism Laboratory, St Vincent’s Hospital, Dublin, Ireland.
ea0025p11
Lithium-induced hypercalcaemia: 'past, present, and future'
Southampton General Hospital, Southampton, UK.
ea0025p12
What predicts adverse outcomes in untreated primary hyperparathyroidism?
University of Dundee, Dundee, UK.
ea0025p13
A gene causing autosomal dominant kyphoscoliosis in an N-ethyl-N-nitrosourea (ENU) mutagenised mouse model is located on a 5 Mb interval on mouse chromosome 4 band A3
Esapa Christopher
Head Rosie
Evans Holly
Thomas Gethin
Brown Matthew
Croucher Peter
Cox Roger
Brown Steve
Thakker Rajesh
1University of Oxford, Oxford, Oxfordshire, UK; 2MRC Harwell, Harwell, Oxfordshire, UK; 3University of Sheffield, Sheffield, UK; 4University of Queensland, Queensland, Australia.
ea0025p14
Parathyroid hormone concentrations in proton pump inhibitor induced hypomagnesaemia
Department of Endocrinology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK.
ea0025p15
Radius bone loss with ageing assessed by high-resolution peripheral computed tomography differs in men and women
Sheffield NIHR Bone Biomedical Research Unit, Sheffield, UK.
ea0025p16
A 5'-untranslated region mutation of the growth and differentiation factor 5 (Gdf5) gene increases expression and is associated with decreased urinary excretion of the cartilage degradation product, CTX-II: relevance to osteoarthritis
1University of Oxford, Oxford, UK; 2MRC Harwell, Oxfordshire, UK.
ea0025p17
The long-term safety and efficacy of zoledronic acid in the treatment of osteoporosis: a 3-year, randomized extension to the HORIZON-pivotal fracture trial (PFT)
Eastell Richard
Reid Ian
Cauley Jane
Boonen Steven
Cosman Felicia
Leung Ping Chung
Lakatos Peter
Man Zulema
Cummings Steven
Hue Trisha
Ruzycky MaryEllen
Martinez Ruvie
Su Guoqin
Bucci-Rechtweg Christina
Black Dennis
1University of Sheffield, Sheffield, UK; 2University of Auckland, Auckland, New Zealand; 3University of Pittsburgh, Pittsburgh, Pennsylvania, USA; 4Katholieke Universiteit Leuven, Leuven, Belgium; 5Helen Hayes Hospital, West Haverstraw, New York, USA; 6Chinese University of Hong Kong, Hong Kong, China; 7Semmelweis University Medical School, Budapest, Hungary; 8Centro Tratamiento Integral Endocrinología, Buenos Aires, Argentina; 9San Francisco Coordinating Center, San Francisco, California, USA; 10University of California, San Francisco, California, USA; 11Novartis Pharmaceuticals, East Hanover, New Jersy, USA.
ea0025p18
Cervical cord compression in a patient with Paget's disease and primary hyperparathyroidism: a diagnostic challenge
1Department of Endocrinology, Royal Preston Hospital, Preston, Lancashire, UK; 2Department of Neurosurgery, Royal Preston Hospital, Preston, Lancashire, UK.
ea0025p19
Localisation studies in primary hyperparathyroidism: our experience
Russells Hall Hospital, Dudley, UK.
ea0025p20
Co-existing sarcoidosis, primary hyperparathyroidism and vitamin D deficiency in a patient with hypercalcaemia
Calderdale Royal Hospital, Halifax, West Yorkshire, UK.
ea0025p21
Immobility: a rare cause of hypercalcaemia
1Diabetes and Endocrinology Unit, Countess of Chester Hospital NHS Foundation Trust, Chester, UK; 2Department of Blood Sciences, Countess of Chester Hospital NHS Foundation Trust, Chester, UK.
ea0025p22
Ablation of AMP-activated protein kinase (AMPK) [alpha]1 catalytic subunit in mice leads to decreased bone loss after ovariectomy and impaired bone response to intermittent PTH treatment
1Veterinary Basic Sciences, Royal Veterinary College, London, UK; 2INSERM U567, Paris, France; 3Endocrinology, Queen Mary University of London, London, UK.
ea0025p23
Management of primary hyperparathyroidism
Walsall Manor Hospital, Walsall, West Midlands, UK.
ea0025p24
Comparison of two high dose- bolus vitamin D regimens in women with low vitamin D levels
Leeds General Infirmary, Leeds, UK.
ea0025p25
Audit of local management of hyperparathyroidism and evaluation of vitamin D deficiency in PHPT
Queen Elizabeth Hospital, Welwyn Garden City, UK.
ea0025p26
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2021 |
Privacy policy |
Cookie settings
BiosciAbstracts
Biosci Abstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.